Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse.
CRISPR/Cas9
CRISPR/Cas9-mediated large genetic modifications in mouse
Gene-editing
Microinjection
Mouse
Streptavidin/biotin
Zygote
ssDNA
Journal
MethodsX
ISSN: 2215-0161
Titre abrégé: MethodsX
Pays: Netherlands
ID NLM: 101639829
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
07
2019
accepted:
05
09
2019
entrez:
1
11
2019
pubmed:
2
11
2019
medline:
2
11
2019
Statut:
epublish
Résumé
Genetically modified model organisms are valuable tools for probing gene function, dissecting complex signaling networks, studying human disease, and more. CRISPR/Cas9 technology has significantly democratized and reduced the time and cost of generating genetically modified models to the point that small gene edits are now routinely and efficiently generated in as little as two months. However, generation of larger and more sophisticated gene-modifications continues to be inefficient. Alternative ways to provide the replacement DNA sequence, method of Cas9 delivery, and tethering the template sequence to Cas9 or the guide RNA (gRNA) have all been tested in an effort to maximize homology-directed repair for precise modification of the genome. We present two CRISPR/Cas9 methods that have been used to successfully generate large and complex gene-edits in mouse. In the first method, the Cas9 enzyme is used in conjunction with two sgRNAs and a long single-stranded DNA (lssDNA) template prepared by an alternative protocol. The second method utilizes a tethering approach to couple a biotinylated, double-stranded DNA (dsDNA) template to a Cas9-streptavidin fusion protein. •Alternative method for generating long, single-stranded DNA templates for CRISPR/Cas9 editing.•Demonstration that using two sgRNAs with Cas9-streptavidin/biotinylated-dsDNA is feasible for large DNA modifications.
Identifiants
pubmed: 31667107
doi: 10.1016/j.mex.2019.09.003
pii: S2215-0161(19)30224-9
pmc: PMC6812322
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2088-2100Subventions
Organisme : NIAMS NIH HHS
ID : R61 AR073523
Pays : United States
Informations de copyright
© 2019 The Authors.
Références
Elife. 2017 May 02;6:
pubmed: 28462777
Nat Biotechnol. 2018 Aug;36(7):632-637
pubmed: 29889212
Nat Commun. 2017 Nov 23;8(1):1711
pubmed: 29167458
Commun Biol. 2018 May 31;1:54
pubmed: 30271937
Cell. 2013 Sep 12;154(6):1370-9
pubmed: 23992847
Genetics. 2015 Jan;199(1):1-15
pubmed: 25271304
Cell Res. 2017 Apr;27(4):578-581
pubmed: 28266543
Nat Protoc. 2014 Aug;9(8):1956-68
pubmed: 25058643
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Sci Rep. 2015 Aug 05;5:12799
pubmed: 26242611
BMC Biol. 2018 Jun 21;16(1):70
pubmed: 29925374
Cell. 2013 May 9;153(4):910-8
pubmed: 23643243
Genome Biol. 2017 May 17;18(1):92
pubmed: 28511701
BMC Biol. 2018 Jun 21;16(1):69
pubmed: 29925370